YOLFTbeta
Vericel Corp Ord

Vericel Corp Ord

VCEL · NASDAQ · Healthcare / Biotechnology

56.96USD-0.46 (-0.80%)

Price History

Full chart

Market Stats

Previous Close57.42
Open57.66
Day Range56.86 – 58.42
52-Week Range28.95 – 49.32
Volume698.80K
Market Cap2.03B
P/E (TTM)82.73
Forward P/E57.14
EPS0.48
Dividend Yield0.00%
Beta1.05
50-Day Avg42.85
200-Day Avg38.19

About

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Dominick C. Colangelo Esq.
  • Employees398
  • Headquarters25 Blue Sky Drive, Burlington, MA, United States, 01803, USA
  • Websitehttps://www.vcel.com

Leadership

  • Mr. Dominick C. Colangelo Esq.CEO, President & Director · b. 1964
  • Mr. Joseph Anthony Mara Jr.CFO & Treasurer · b. 1976
  • Mr. Michael HalpinChief Operating Officer · b. 1962
  • Mr. Sean C. FlynnChief Legal Officer · b. 1974
  • Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.Chief Medical Officer · b. 1962
  • Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller
  • Mr. Eric BurnsVice President of Finance & Investor Relations
  • Mr. Roland DeAngelisChief Marketing Officer
  • Mr. Patrick J. FowlerSenior Vice President of Corporate Development & Strategy
  • Mr. Mike GilliganSenior Vice President of Sales

Financials

Income Statement

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.60M400.00K400.00K249.00K881.00K1.15M899.00K877.00K844.00K1.30M909.00K863.00K685.00K522.00K182.00K89.00K18.00K21.00K19.00K28.80M51.17M54.38M63.92M90.86M117.85M124.18M156.18M164.37M197.52M237.22M276.26M
Growth (%)--75.00%0.00%-37.75%+253.82%+30.53%-21.83%-2.45%-3.76%+54.27%-30.18%-5.06%-20.63%-23.80%-65.13%-51.10%-79.78%+16.67%-9.52%+151457.89%+77.69%+6.28%+17.54%+42.13%+29.71%+5.37%+25.77%+5.24%+20.17%+20.10%+16.45%
Cost of Revenue9.60M-500.00K-500.00K6.00K6.00K926.00K13.00K202.00K893.00K280.00K148.00K11.00K29.00K56.00K112.00K34.00K4.00K6.00K4.00K17.29M26.47M28.31M30.35M32.16M37.57M39.95M50.16M54.58M61.94M65.12M70.66M
Gross Profit-8.00M900.00K900.00K249.00K875.00K224.00K886.00K675.00K-49.00K1.02M761.00K852.00K656.00K466.00K70.00K55.00K14.00K15.00K15.00K11.50M24.70M26.08M33.57M58.70M80.28M84.23M106.03M109.79M135.58M172.11M205.60M
Gross Margin-500.00%225.00%225.00%100.00%99.32%19.48%98.55%76.97%-5.81%78.49%83.72%98.73%95.77%89.27%38.46%61.80%77.78%71.43%78.95%39.95%48.27%47.95%52.52%64.60%68.12%67.83%67.88%66.80%68.64%72.55%74.42%
Operating Expense2.50M15.90M15.90M18.36M13.71M9.98M7.46M8.96M9.66M11.68M13.18M18.59M20.13M21.68M16.24M17.86M29.05M33.77M20.98M35.04M41.37M45.32M48.55M62.61M91.53M81.86M113.88M126.85M142.04M167.59M194.56M
Operating Income-10.50M-15.00M-15.00M-18.11M-12.83M-9.75M-6.58M-8.28M-9.71M-10.66M-12.42M-17.73M-19.47M-21.22M-16.17M-17.80M-29.04M-33.76M-20.96M-23.53M-16.67M-19.25M-14.98M-3.91M-11.25M2.37M-7.85M-17.06M-6.46M4.52M11.04M
Operating Margin-656.25%-3750.00%-3750.00%-7271.89%-1456.53%-848.17%-731.81%-944.24%-1150.83%-818.51%-1366.01%-2054.81%-2842.19%-4064.94%-8884.07%-20004.49%-161333.33%-160761.90%-110336.84%-81.73%-32.58%-35.39%-23.44%-4.30%-9.55%1.91%-5.03%-10.38%-3.27%1.90%4.00%
EBITDA-14.50M-13.80M-17.75M-12.62M-9.43M-6.48M-8.15M-9.71M-10.36M-12.42M-17.73M-19.47M-19.52M-15.46M-17.80M-30.15M-19.01M-28.81M-15.12M-19.16M-14.74M-17.37M-14.57M-4.98M-7.91M5.43M-4.61M-11.64M2.86M16.63M30.29M
EBITDA Margin-906.25%-3450.00%-4437.75%-5067.87%-1070.26%-563.22%-907.12%-1107.53%-1227.84%-953.69%-1950.83%-2255.97%-2849.05%-2962.64%-9782.42%-33874.16%-105616.67%-137204.76%-79589.47%-66.54%-28.81%-31.93%-22.79%-5.48%-6.71%4.38%-2.95%-7.08%1.45%7.01%10.97%
Net Income-9.90M-14.30M-14.30M-17.23M-11.03M-9.39M-5.93M-7.94M-9.58M-10.49M-11.81M-16.48M-17.59M-20.13M-15.95M-17.73M-19.67M-29.47M-15.62M-19.92M-16.34M-19.57M-17.29M-8.14M-9.66M2.86M-7.47M-16.71M-3.18M10.36M16.52M
Net Income Margin-618.75%-3575.00%-3575.00%-6920.88%-1251.76%-816.52%-659.18%-905.25%-1134.95%-805.53%-1299.34%-1909.04%-2568.47%-3856.90%-8761.54%-19920.22%-109266.67%-140352.38%-82221.05%-69.18%-31.93%-35.98%-27.04%-8.96%-8.20%2.31%-4.78%-10.17%-1.61%4.37%5.98%
R&D-13.40M13.40M15.50M10.87M6.29M4.98M5.43M5.65M6.29M7.21M9.48M11.44M15.25M11.29M12.66M21.33M26.02M15.10M21.26M18.89M15.29M12.94M13.60M30.39M13.02M16.29M19.94M21.04M24.80M27.56M
R&D as % of Total Revenue-3350.00%3350.00%6224.10%1233.94%546.87%554.28%618.93%669.08%483.03%792.74%1098.96%1670.51%2921.26%6202.75%14222.47%118500.00%123928.57%79494.74%73.84%36.92%28.12%20.25%14.97%25.79%10.48%10.43%12.13%10.65%10.45%9.98%
Interest Expense00000000000084.00K73.00K73.00K40.00K10.00K12.00K11.00K6.00K9.00K314.00K1.11M1.73M8.00K6.00K4.00K366.00K600.00K614.00K1.56M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%12.26%13.98%40.11%44.94%55.56%57.14%57.89%0.02%0.02%0.58%1.73%1.91%0.01%0.00%0.00%0.22%0.30%0.26%0.56%

Balance Sheet

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.10M18.40M20.91M12.37M9.54M13.44M11.90M11.55M12.15M18.17M33.90M44.88M32.85M26.22M19.28M32.83M7.74M15.18M9.21M47.58M34.31M48.60M54.58M118.69M153.24M205.61M243.71M273.00M353.66M432.72M487.97M
Total Liabilities1.30M1.80M2.10M1.53M1.03M1.00M1.01M750.00K580.00K558.00K869.00K2.54M4.60M2.88M1.99M29.91M20.71M5.67M5.32M11.94M12.18M23.89M32.04M16.46M42.15M71.35M73.24M80.73M127.70M140.75M133.33M
Total Equity4.80M16.60M18.81M10.85M8.51M12.44M10.89M10.80M11.57M17.61M33.03M42.34M28.25M23.33M17.28M2.92M-12.97M9.51M3.89M35.64M22.13M24.71M22.54M102.23M111.09M134.26M170.46M192.27M225.95M291.97M354.64M
Cash4.10M1.90M1.27M2.08M7.53M2.06M10.66M8.61M10.51M16.93M14.41M9.03M13.44M16.49M17.00M31.25M5.53M13.64M8.06M30.34M14.58M22.98M26.86M18.29M26.89M33.62M68.33M51.07M69.09M74.52M100.09M
Total Debt300.00K200.00K101.00K65.00K-------1.54M1.54M1.23M784.00K255.00K80.00K40.00K6.00K109.00K71.00K10.13M17.24M-27.85M53.30M50.18M47.57M88.04M98.85M98.27M
Net Debt-3.80M-1.70M-1.17M-2.01M-7.53M-2.06M-10.66M-8.61M-10.51M-16.93M-14.41M-7.50M-11.90M-15.26M-16.22M-30.99M-5.45M-13.60M-8.05M-30.23M-14.51M-12.85M-9.62M-18.29M965.00K19.68M-18.15M-3.50M18.95M24.33M-1.83M

Cash Flow

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.10M-13.30M-13.30M-15.64M-11.20M-6.88M-6.36M-8.75M-8.99M-9.53M-11.06M-13.52M-14.83M-19.53M-13.80M-15.09M-24.49M-29.55M-19.94M-25.41M-13.35M-19.89M-13.18M-412.00K-7.18M17.57M29.04M17.69M35.31M58.16M51.91M
Investing Cash Flow8.10M--15.40M5.89M9.13M-10.80M10.69M-1.15M881.00K-157.00K-18.52M-16.61M18.56M9.08M--5.12M-1.03M-273.00K-40.00K-2.18M-2.39M-1.42M-1.51M-67.03M10.62M-17.16M-3.50M-36.21M-3.13M-79.03M-43.94M
Financing Cash Flow9.30M19.70M19.70M9.88M7.52M12.21M4.26M7.85M10.02M16.10M27.07M24.75M671.00K13.50M8.35M17.32M-195.00K37.93M14.40M49.93M-24.00K29.70M18.58M58.86M5.26M6.44M9.17M1.04M3.62M19.05M7.07M
Capital Expenditure400.00K400.00K400.00K234.00K73.00K136.00K58.00K153.00K119.00K157.00K586.00K789.00K1.06M215.00K35.00K120.00K1.03M273.00K40.00K829.00K2.43M1.42M1.51M2.68M2.62M2.63M7.92M7.60M27.51M63.97M27.16M
Free Cash Flow-9.50M-13.70M-13.70M-15.87M-11.27M-7.01M-6.42M-8.90M-9.11M-9.68M-11.65M-14.31M-15.89M-19.74M-13.84M-15.21M-25.52M-29.82M-19.98M-26.24M-15.77M-21.31M-14.69M-3.09M-9.80M14.95M21.13M10.09M7.80M-5.81M24.75M
Dividends Paid----------------0000000--------
FCF to OCF104.40%103.01%103.01%101.50%100.65%101.98%100.91%101.75%101.32%101.65%105.30%105.84%107.18%101.10%100.25%100.80%104.21%100.92%100.20%103.26%118.19%107.11%111.45%750.00%136.42%85.06%72.74%57.05%22.08%-9.99%47.67%
Dividend Paid to FCF----------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateSep 30, 1997Dec 31, 1997Mar 31, 1998Jun 30, 1998Sep 30, 1998Dec 31, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Dec 31, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Jan 29, 2003May 12, 2003Aug 26, 2003Nov 10, 2003Feb 4, 2004Apr 29, 2004Sep 8, 2004Nov 4, 2004Feb 4, 2005May 6, 2005Sep 8, 2005Nov 9, 2005Feb 8, 2006May 10, 2006Sep 13, 2006Nov 9, 2006Feb 7, 2007May 8, 2007Sep 10, 2007Nov 9, 2007Feb 8, 2008May 12, 2008Aug 29, 2008Nov 7, 2008Feb 6, 2009May 8, 2009Sep 15, 2009Nov 6, 2009Feb 10, 2010May 10, 2010Aug 17, 2010Nov 8, 2010Feb 28, 2011May 16, 2011Aug 15, 2011Nov 8, 2011Mar 12, 2012May 10, 2012Aug 7, 2012Nov 8, 2012Mar 18, 2013May 8, 2013Aug 7, 2013Nov 12, 2013Mar 13, 2014May 15, 2014Aug 14, 2014Nov 13, 2014Mar 23, 2015May 14, 2015Aug 12, 2015Nov 13, 2015Mar 14, 2016May 10, 2016Aug 8, 2016Nov 7, 2016Mar 10, 2017May 10, 2017Aug 9, 2017Nov 7, 2017Mar 5, 2018May 8, 2018Aug 6, 2018Nov 6, 2018Feb 26, 2019May 7, 2019Aug 6, 2019Nov 5, 2019Feb 25, 2020May 5, 2020Aug 5, 2020Nov 5, 2020Feb 24, 2021May 5, 2021Aug 4, 2021Nov 9, 2021Feb 24, 2022May 4, 2022Aug 3, 2022Nov 9, 2022Feb 23, 2023May 10, 2023Aug 2, 2023Nov 8, 2023Feb 29, 2024May 8, 2024Aug 1, 2024Nov 7, 2024Feb 26, 2025May 8, 2025Jul 31, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Jul 30, 2026Nov 5, 2026
EPS Estimate-------------------------------4.80-5.60-5.87-6.40-6.93-5.87-6.40-6.40-6.40-6.40-6.40-6.40-6.93-6.40--------3.00-3.55-3.35-3.47-3.40-3.75-4.60-4.12-4.82-4.40-4.54-3.71-2.40-1.40-1.33-0.82-1.27-0.60-0.46-0.17-0.18-0.21-0.14-0.25-0.16-0.18-0.18-0.16-0.19-0.16-0.07-0.13-0.12-0.110.04-0.07-0.06-0.020.20-0.08-0.20-0.020.20-0.04-0.09-0.020.14-0.12-0.12-0.100.04-0.16-0.15-0.120.17-0.10-0.09-0.050.34-0.15-0.04-0.010.45-0.16-0.040.02
EPS Actual-43.68-95.19-66.22-46.89-42.82-26.22-32.59-20.96-34.20-19.96-14.25-9.24-6.68-4.33-8.11-8.88-7.58-7.63-7.80-6.40-8.74-7.54-6.51-7.43-6.43-5.39-5.54-5.45-5.12-4.39-4.80-4.80-4.80-6.40-6.40-6.40-4.80-6.40-6.40-6.40-6.40-6.40-6.40-6.40-4.71-4.88-4.33-3.20-3.68-4.21-0.40-3.60-4.20-8.80-2.60-5.20-1.00-1.40-5.00-4.40-3.40-3.60-3.00-2.20-1.20-0.97-1.260.09-0.52-0.17-0.27-0.16-0.26-0.02-0.08-0.21-0.27-0.23-0.31-0.07-0.130.03-0.21-0.12-0.020.13-0.07-0.050.070.20-0.10-0.180.080.25-0.07-0.08-0.110.09-0.15-0.19-0.140.12-0.16-0.11-0.050.26-0.08-0.10-0.020.38-0.23-0.010.100.45-0.120.04-
Surprise------------------------------0.00%14.29%18.23%0.00%7.65%-9.03%25.00%0.00%0.00%0.00%0.00%0.00%7.65%0.00%--------20.00%-18.31%-162.69%25.07%-52.94%73.33%69.57%-21.36%8.71%22.73%20.70%19.14%8.33%14.29%27.07%-53.66%107.09%13.33%63.04%-58.82%11.11%-23.81%85.71%68.00%-31.25%-50.00%-27.78%-93.75%63.16%18.75%142.86%-61.54%0.00%81.82%225.00%0.00%16.67%450.00%0.00%-25.00%10.00%500.00%25.00%-75.00%11.11%-450.00%-35.71%-25.00%-58.33%-40.00%200.00%0.00%26.67%58.33%52.94%20.00%-11.11%60.00%11.76%-53.33%75.00%1100.00%0.00%25.00%200.00%-
Timing---------------------------------------------------Pre-market--After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.03B
Enterprise Value1.92B
Trailing P/E82.73
Forward P/E57.14
PEG Ratio0.00
Price / Sales6.64
Price / Book5.37
EPS0.48
Book Value7.23
Revenue (TTM)306.30M
Gross Profit (TTM)228.38M
EBITDA31.15M
Profit Margin7.91%
Operating Margin0.56%
Return on Equity7.16%
Return on Assets2.43%
Shares Outstanding51.21M
Shares Float50.58M
Beta1.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 8 analystsTarget 60.57
  • Strong Buy
    7
  • Buy
    1

Ownership Breakdown

Institutions
111.04%
Insiders
1.19%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    7.77M15.16%
  • State Street Corp
    3.15M6.16%
  • Congress Asset Management Company, LLP
    2.92M5.70%
  • Vanguard Capital Management, LLC
    2.23M4.36%
  • Conestoga Capital Advisors, LLC
    2.08M4.07%
  • William Blair Investment Management, LLC
    1.99M3.89%
  • BNP Paribas Investment Partners SA
    1.72M3.37%
  • GW&K Investment Management, LLC
    1.62M3.16%
  • Soleus Capital Management, L.P.
    1.46M2.85%
  • Geneva Capital Management
    1.34M2.62%
  • Geode Capital Management, LLC
    1.25M2.45%
  • Loomis, Sayles & Company LP
    1.20M2.34%
  • Bank of America Corp
    1.10M2.15%
  • Vanguard Portfolio Management, LLC
    991.63K1.94%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    3.11M6.07%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.62M3.17%
  • iShares Russell 2000 ETF
    1.32M2.57%
  • State Street® SPDR® S&P® Biotech ETF
    1.26M2.46%
  • Congress Small Cap Growth Institutional
    1.17M2.28%
  • Conestoga Small Cap Investors
    1.16M2.26%

Stock Splits

  • Oct 16, 20131:20
  • Feb 18, 20101:8